Application for the importation of cannabis based products or synthetic cannabinoid products in accordance with the Medicines Act and the Drug Dependence (Treatment not Imprisonment, Act)
Medical Product Alert N°2/2026: Falsified JAKAVI (ruxolitinib) Falsified JAKAVI (ruxolitinib) identified in the WHO Eastern Mediterranean and European regions